Mechanism of Bone Growth : Research on proliferation and apoptosis of growth plate chondrocyte.
Mechanism of Bone Growth : Research on proliferation and apoptosis of growth plate chondrocyte.
批准号:
12470220
负责人:
SEINO Yoshiki
金额:
$9.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We aimed to explore molecular basis of the cell proliferation, differentiation, and cell death(apoptosis) of the growth plate chondrocyte in this project. To this aid, we selected achondroplasia as a model disorder of growth plate chondrocyte. The responsible gene to this disorder is the gene coding fibroblast growth factor receptor 3 (FGFR3). The major mutation is G380R, which activate receptor constitutively. And related severe form, thanatophoric dysplasia is due to the mutation, K650E, which induce receptor activation more profoundly. We at first introduced these mutations into chondrogenic cell line, ATDC5, and studied phenotypic change of these cells. The chondrocytes expressing mutated FGFR3 showed deteriorated cell growth and increased apoptosis. The inhibition of the cell growth was mediated by the activation of p21 and increased apoptosis was due to the decreased bcl-2 expression. Moreover K650E mutation induced stat 1 activation and its nuclear translocation and this event l … More ooked to located upstream of deteriorated cell growth and increased apoptosis. IGF-I induced by the Growth hormone treatment may activate PI3K and then increase bcl-2 expression. This mechanism may be responsible to the rescue chondrocyte from apoptosis and to GH stimulated bone growth in achondroplasia.From thee analogy of achondroplasia to PTHrP KO mice, we next studied PTHrP expression in this cellular model. The cells expressing mutated FGFR3 showed decreased expression of PTHrP mRNA. Moreover, this decrease was more severe in K650E mutation. Next we administered PTHrP to the cells by several methods and confirmed that PTHrP signal may blockk pathogenic pathway induced by constitutively activated FGFR3 and rescue the cells from apoptosis. Bone organ culture system using cartilage specific mutated FGFR3 transgenic mice showed increased bone length, which was mainly due to the expansion of proliferative chondrocyte zone. In vivo experiment similarly indicates promising effect of PTH on the bone growth of achondroplasia. Less
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yamashita N, Tanaka H, Moriwake T, Nishiuchi R, Oda M, Seino Y.: "Analysis of linear growth in survivors of childhood acute lymphoblastic leukemia."J Bone Miner Metab. 21. 172-178 (2003)
Yamashita N、Tanaka H、Moriwake T、Nishiuchi R、Oda M、Seino Y.:“儿童急性淋巴细胞白血病幸存者的线性生长分析。”J Bone Miner Metab。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaru Inoue: "Altered biochemical markers of bone turnover in humans during 120 days of bed rest"
Masaru Inoue:“在 120 天卧床休息期间,人类骨转换的生化标志物发生了变化”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seino Y: "Growth hormone therapy in achondroplasia."Horm Res. 53. 53-56 (2000)
Seino Y:“软骨发育不全的生长激素疗法。”Horm Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koike M: "Insulin-like growth factor-1 (IGF-1) rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase"J Bone Miner Res. 18. 2043-2051 (2003)
Koike M:“胰岛素样生长因子-1 (IGF-1) 通过磷脂酰肌醇 3-激酶拯救表达突变 FGF 受体 3 (G380R) 的 ATDC5 细胞免于凋亡”J Bone Miner Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamanaka Y: "Molecular basis for the treatment of achondroplasia."Horm Res. 60. 60-64 (2003)
Yamanaka Y:“治疗软骨发育不全的分子基础。”Horm Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Pathophysiologic mechanisms of the abnormal parathyroid hormone secretion
-
批准号:09470223
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.74万
-
财政年份:1997
-
负责人:SEINO Yoshiki
-
依托单位:
The roles of vitamin D and growth factors in the pathogenesis of renal osteodystrophy
-
批准号:06454353
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.86万
-
财政年份:1994
-
负责人:SEINO Yoshiki
-
依托单位:
Serum Propeptide and Intact Molecular Osteocalcin in Normal Children and Children with Growth Hormone(GH) Deficiency
-
批准号:04670598
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1992
-
负责人:SEINO Yoshiki
-
依托单位:
1alpha, 25 - (OH)_2 D_3 - 26, 23 - lactone stimulates bone formation.
-
批准号:01570528
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1989
-
负责人:SEINO Yoshiki
-
依托单位:
Measurement of 1,25(OH)_2D_3 receptors in vitamin D resistant diseases.
-
批准号:61570455
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1986
-
负责人:SEINO Yoshiki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TBX3通过FGFR3/PI3K/AKT反馈环路促进肿瘤相关成纤维细胞屏障形成并降低CD8+T细胞趋化导致膀胱癌免疫治疗耐受的机制研究
-
批准号:2025JJ81043
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:匡小根
-
依托单位:
SP1通过FGFR3/PI3K/AKT信号通路在缺血性股骨头坏死模型小鼠骨修复中的调节作用探究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨彦才
-
依托单位:
FGFR3 融合蛋白的液液相分离驱动肿瘤发生的分子机制研究
-
批准号:24ZR1404800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:胡小华
-
依托单位:
靶向FGFR3 突变体降解剂的设计、合成及其
在癌症治疗中的应用
-
批准号:Q24H300029
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:叶增辉
-
依托单位:
FGFR3激活突变患扰抑制抗原呈递介导膀胱癌抗PD1/PD-L1免疫治疗原发耐药的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:武文博
-
依托单位:
MSCs来源外泌体miR-99a-5p通过FGFR3/MAPK途径抑制矽肺小鼠纤维
化机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
生物钟因子Rev-erbα转录抑制FGFR3对软骨形成的调控机制和软骨发育不全病的治疗研究
-
批准号:82302655
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:钱庄
-
依托单位:
FGFR3通过m6A甲基化转移酶Mettl3调节LepR+骨髓间充质干细胞成骨成脂分化命运在骨衰老中的作用和机制研究
-
批准号:82372468
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:苏楠
-
依托单位:
WTAP/m6A/FGFR3轴在纤维软骨透明化治疗中的作用与机制研究
-
批准号:82302689
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李嘉威
-
依托单位:
FGFR3突变介导受体过度激活和免疫抑制诱导膀胱癌发生和治疗耐药的分子机制
-
批准号:82373436
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:石铭俊
-
依托单位: